These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7603913)

  • 1. Tumor suppressor gene p53 mutations in human prostate cancer.
    Kubota Y; Shuin T; Uemura H; Fujinami K; Miyamoto H; Torigoe S; Dobashi Y; Kitamura H; Iwasaki Y; Danenberg K
    Prostate; 1995 Jul; 27(1):18-24. PubMed ID: 7603913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma gene mutations in primary human prostate cancer.
    Kubota Y; Fujinami K; Uemura H; Dobashi Y; Miyamoto H; Iwasaki Y; Kitamura H; Shuin T
    Prostate; 1995 Dec; 27(6):314-20. PubMed ID: 7501543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
    Dahiya R; Deng G; Chen KM; Chui RM; Haughney PC; Narayan P
    Br J Cancer; 1996 Jul; 74(2):264-8. PubMed ID: 8688333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.
    Mirchandani D; Zheng J; Miller GJ; Ghosh AK; Shibata DK; Cote RJ; Roy-Burman P
    Am J Pathol; 1995 Jul; 147(1):92-101. PubMed ID: 7604888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and characterization of p53 mutations in clinically localized prostate cancer.
    Hall MC; Navone NM; Troncoso P; Pollack A; Zagars GK; von Eschenbach AC; Conti CJ; Chung LW
    Urology; 1995 Mar; 45(3):470-5. PubMed ID: 7879337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer.
    Suzuki H; Komiya A; Aida S; Ito H; Yatani R; Shimazaki J
    Prostate; 1996 May; 28(5):318-24. PubMed ID: 8610059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.
    Mottaz AE; Markwalder R; Fey MF; Klima I; Merz VW; Thalmann GN; Ball RK; Studer UE
    Prostate; 1997 Jun; 31(4):209-15. PubMed ID: 9180930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of MDM2 in prostate carcinoma.
    Leite KR; Franco MF; Srougi M; Nesrallah LJ; Nesrallah A; Bevilacqua RG; Darini E; Carvalho CM; Meirelles MI; Santana I; Camara-Lopes LH
    Mod Pathol; 2001 May; 14(5):428-36. PubMed ID: 11353053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer.
    Uchida T; Wada C; Shitara T; Egawa S; Koshiba K
    Br J Cancer; 1993 Oct; 68(4):751-5. PubMed ID: 7691145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].
    Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C
    Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations occur in clinical, but not latent, human prostate carcinoma.
    Konishi N; Hiasa Y; Hayashi I; Matsuda H; Tsuzuki T; Ming T; Kitahori Y; Shiraishi T; Yatani R; Shimazaki J
    Jpn J Cancer Res; 1995 Jan; 86(1):57-63. PubMed ID: 7737911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay.
    Shi XB; Bodner SM; deVere White RW; Gumerlock PH
    Diagn Mol Pathol; 1996 Dec; 5(4):271-8. PubMed ID: 8955619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
    Yamashita K; Yoshida T; Shinoda H; Okayasu I
    Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 is mutated in a subset of advanced-stage prostate cancers.
    Bookstein R; MacGrogan D; Hilsenbeck SG; Sharkey F; Allred DC
    Cancer Res; 1993 Jul; 53(14):3369-73. PubMed ID: 8324747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.